Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSerious allergic reactions to semaglutide are uncommon, but they do happen, and knowing what to look for matters. Most people tolerate Wegovy well; a minority experience injection-site redness or mild skin changes that are not a true allergy. A smaller number develop signs of a genuine hypersensitivity response that needs prompt attention. Semaglutide is a prescription-only medicine, and a clinician assesses your full health picture, including any history of drug reactions, before prescribing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The honest answer is that the term gets used loosely. A raised, itchy patch at the injection site is unpleasant, but it is usually a local inflammatory response rather than a systemic allergy. If you want to understand what being allergic to semaglutide actually means clinically, a genuine hypersensitivity reaction involves the immune system mounting a response to the medicine itself, and the signs appear across the body rather than just where the pen touched skin.
Mild-to-moderate allergic reactions to Wegovy can include generalised hives (urticaria) spreading beyond the injection area, persistent itching across the torso or limbs, flushing and swelling that is not confined to one spot. These deserve the same day contact with your prescriber or pharmacist, not a wait-and-see approach. The NHS semaglutide page lists rash, itching and swelling among the side effects to tell a doctor or pharmacist about promptly.
Injection-site reactions, by contrast, often settle within a few minutes to hours. Rotating where you inject each week helps considerably. For a closer look at skin-specific responses, the Wegovy skin reactions page covers that territory in detail. If you have had a drug reaction before, that history is exactly the kind of thing our prescribers ask about during your consultation, before any treatment begins.
Anaphylaxis is the most serious end of the allergic-reaction spectrum, and it demands immediate action. Call 999 if you or someone nearby develops any of the following after a Wegovy injection: throat tightening or swelling that makes swallowing or breathing harder, a hoarse voice that appeared suddenly, wheezing, a skin reaction combined with dizziness or a feeling of faintness, or a sudden drop in alertness. These signs can appear within minutes and can escalate quickly.
One practical habit worth building: after every new injection or dose increase, stay somewhere you are not alone for about 20 to 30 minutes. Glancing in a mirror to check for facial swelling or lip puffiness takes under a minute and gives you an early prompt to act if something feels off. It is a simple check, not a clinical test, but it can make a difference.
If you carry an adrenaline auto-injector for any other condition, your prescriber needs to know before semaglutide is started. The guide to bad reactions to semaglutide covers the range of severe responses worth being aware of. Stopping the medicine without clinical advice is not recommended either; your prescriber will guide you on next steps after any reaction.
This distinction trips people up, and it is worth being clear about it. Local injection-site reactions, such as a small red bump, brief stinging, mild bruising or a firm nodule under the skin, are very common and not a sign that your immune system is rejecting the medicine. They tend to peak around 24 hours after the injection and fade without treatment. Rotating injection sites between the abdomen, thigh and upper arm each week reduces their frequency markedly.
A systemic or generalised allergic reaction behaves differently: it spreads, it does not stay at the injection point, and it may involve multiple body systems at once. Hives on the back an hour after injecting into the abdomen, a racing heart alongside flushing, or nausea accompanying a skin rash are patterns that should prompt a same-day call rather than reassurance. The overview of Wegovy reactions maps this distinction further.
The full side-effect profile of semaglutide is considerably broader than skin reactions alone. If you want the wider picture, the Wegovy side effects page runs through the gastrointestinal, cardiovascular and other effects documented in trials and clinical practice. For raw semaglutide side-effect data from the trial programme, the clinical trial side-effect breakdown is worth reading alongside this page.
If you think you are having an anaphylactic reaction, call 999 first. Do not wait to contact your prescriber, do not drive yourself anywhere, and do not take an antihistamine and hope it resolves.
For reactions that are concerning but not an emergency, contact your prescriber the same day. At nume, our clinical team is available seven days a week for exactly this kind of situation; you can reach us via the contact page. Do not simply stop injecting without speaking to someone first, because abrupt discontinuation may need to be managed depending on your treatment history.
All suspected side effects from prescription medicines can be reported to the MHRA through the Yellow Card scheme. You do not need a healthcare professional to submit a report; patients and carers can do it directly. These reports genuinely inform ongoing safety monitoring of medicines like semaglutide, and the MHRA reviews them as part of its continuous post-market surveillance.
If you are weighing up whether semaglutide is the right option given your personal history of allergies or sensitivities, the consultation with our prescribers is the right place to start. Side-effect risk, contraindications and your health history are reviewed together, not in isolation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.